[Tolerance of barbiturates in patients with viral hepatitis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D003577:Cytochrome P-450 Enzyme System / Q000097:blood; D004361:Drug Tolerance; D006506:Hepatitis A / Q000378:metabolism*; D006591:Hexobarbital / Q000008:administration & dosage* / Q000378:metabolism; D006801:Humans; D007275:Injections, Intravenous; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D008875:Middle Aged; D009249:NADP / Q000378:metabolism; D010088:Oxidoreductases / Q000378:metabolism
D009249:NADP; D003577:Cytochrome P-450 Enzyme System; D006591:Hexobarbital; D010088:Oxidoreductases; D000410:Alanine Transaminase; D001663:Bilirubin
Sulla questione della tollerabilità dei barbiturici nei pazienti affetti da virusepatite.